A real-time PCR assay for HPV52 detection and viral load quantification

Area of Science:

• Virology
• Molecular Biology
• Infectious Diseases

Background:

• Human Papillomavirus (HPV) 52 is a high-risk type prevalent in cervical and anal infections.
• Current assays like Roche Linear Array (LA) lack specificity for HPV 52 due to cross-reactivity with other HPV types.

Purpose of the Study:

• To develop and validate a precise real-time TaqMan PCR assay for unambiguous HPV 52 detection.
• To improve diagnostic accuracy and reliability in HPV typing.

Main Methods:

• A real-time TaqMan PCR assay targeting the HPV 52 E6/E7 region was developed.
• The assay was validated as a duplex assay (with beta-globin control) and a single-plex assay.
• Optimized primer and probe concentrations ensured linear amplification and determined detection limits.

Main Results:

• The assay demonstrated high sensitivity with detection limits of 10 copies (duplex) and 5 copies (single-plex) per reaction.
• Excellent type-specificity was confirmed, with no cross-reactivity with related HPV types (33, 35, 58).
• The assay confirmed 92.6% (duplex) and 99.5% (single-plex) accuracy compared to the LA assay, with 10.8% of samples requiring this assay for definitive typing.

Conclusions:

• The developed real-time PCR assay offers superior accuracy and specificity for HPV 52 detection compared to the LA assay.
• This assay is crucial for unequivocal HPV 52 status determination in epidemiological studies.
• The duplex format aids in quality control by monitoring cellular yield during sample processing.